Ember Therapeutics is a product-focused company translating its world-class biology in the emerging area of brown fat and recent breakthroughs in understanding the mechanisms of selective insulin sensitivity into a proprietary pipeline of peripherally-acting treatments for metabolic disease, including Type 2 diabetes and obesity.
3.28.12
Ember Therapeutics Secures Exclusive License to Key Brown Fat Technology and Intellectual Property from the Joslin Diabetes Center
Read More
